What is happening
EQT AB is exploring options for Indira IVF Hospital Ltd., including a sale, say people who asked not to be identified because the talks are private. The firm has brought in an adviser and is testing preliminary appetite from potential buyers, while still weighing whether to move ahead or keep the business.
What price is in play
Those familiar with the situation said EQT could look for a valuation of no less than $1.5 billion for Indira IVF. EQT's representative would not provide a comment.
Track record and scale
In July 2023, EQT reached a deal to purchase Indira IVF from TA Associates. In 2025, it filed a draft initial public offering prospectus for the company, which was later withdrawn. EQT describes Indira IVF as India's biggest provider of fertility clinics, and the company's website lists more than 200 centers across the country.
When ownership and deal talk surface, it helps to stay informed; sign up for the free daily Market Briefs
Why it matters for your portfolio
A potential sale alongside a previously attempted IPO suggests EQT is testing routes to lock in value, and the $1.5 billion marker creates a reference point for India's healthcare services comps. For investors tracking private equity exits and healthcare rollups, watch whether EQT launches a formal auction or stands down, since that choice could influence sentiment and pricing across similar assets.
Whether you follow hospitals, private equity or broader markets, quick clarity matters, so subscribe to the free Market Briefs newsletter
